author-photo

Morgan E. Stewart

University of Texas MD Anderson Cancer Center

3

Papers

138

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

A phase 2 trial of immunotherapy with mitumprotimut-T (Id-KLH) and GM-CSF following rituximab in follicular B-cell lymphoma.

2010 Journal of Immunotherapy
Show All
- Source
- Cite
- Save
Citations (8)
A Placebo-Controlled Phase III Trial of Patient-Specific Immunotherapy with Mitumprotimut-T (ID-KLH) and GM-CSF Following Rituximab in Patients with CD20+ Follicular Lymphoma

2008 Blood
Show All
- Source
- Cite
- Save
Citations (10)